S
The startup develops neurorestorative medicine technology that isolates, purifies, and expands human fibroblast-like neuroprogenitor cells from skin samples to create personalized neuronal cultures. This approach enables healthcare providers to treat Alzheimer's and Parkinson's disease by providing tailored cellular therapies for neurological disorders.
Updated 3 months ago
Funding
$15M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops neurorestorative medicine technology that isolates, purifies, and expands human fibroblast-like neuroprogenitor cells from skin samples to create personalized neuronal cultures. This approach enables healthcare providers to treat Alzheimer's and Parkinson's disease by providing tailored cellular therapies for neurological disorders.